Exercise for Peripheral Neuropathy
Trial Summary
What is the purpose of this trial?
This phase II trial studies whether using exercise is better than the usual approach for treating chemotherapy-induced peripheral neuropathy (CIPN). CIPN occurs when chemotherapy damages the nerves communicating between the brain, spinal cord, and the rest of the body. The usual approach for treating CIPN is treatment with drugs that help reduce symptoms of other types of neuropathy (for example, from diabetes). However, these drugs do not treat all symptoms of CIPN. Exercise may help to reduce CIPN symptoms.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current medications, especially since the trial focuses on exercise as a treatment.
What data supports the effectiveness of this treatment for peripheral neuropathy?
Is exercise safe for people with peripheral neuropathy?
How is the exercise treatment for peripheral neuropathy different from other treatments?
The exercise treatment for peripheral neuropathy is unique because it focuses on improving physical function, strength, and balance through aerobic and resistance training, rather than using medication. This approach can enhance quality of life and physical capabilities, offering psychosocial benefits and potentially reducing symptoms without the side effects associated with drugs.12349
Research Team
Ian R Kleckner
Principal Investigator
University of Rochester NCORP Research Base
Eligibility Criteria
This trial is for adults with cancer who have nerve damage from chemotherapy, can understand English, and are expected to live at least six more months. They should be able to do some exercise and not have other health issues that make exercising unsafe. People who've had recent surgery or radiation (except hormone/biologic therapy) or already exercise regularly can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-week home-based individually tailored progressive exercise intervention or standard care
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Exercise Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester NCORP Research Base
Lead Sponsor
National Cancer Institute (NCI)
Collaborator